Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...

US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...

India's Zydus Lifesciences has entered into a strategic deal to acquire select assets of Sterling Biotech, strengthening its ...

Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...

Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...

The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...

Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...

UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...

Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this ...

Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...

US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific ...

GSK (LSE: GSK) has terminated its neurodegeneration collaboration with Alector (Nasdaq: ALEC), ending an alliance established ...